ESMO 2026

HONG KONG, SHANGHAI and FLORHAM PARK, N.J. — September 29, 2026 HUTCHMED (China) Limited announced that AstraZeneca has submitted...

NEW YORK — September 28, 2026 Pfizer Inc. announced that it will present data from 45 company-sponsored, investigator-sponsored and...

OSAKA, Japan and CAMBRIDGE, Mass. — September 22, 2026 Takeda announced that new data from its oncology pipeline and...

NANTES, France — September 23, 2026 OSE Immunotherapeutics announced that topline results from the Combi-TED Phase 2 trial of...

Hong Kong, China, September 21, 2026 Akeso, Inc. has announced that nearly 30 clinical studies from its innovative biopharmaceutical...

Miramar, Fla., July 27, 2026 DifGen Pharmaceuticals LLC has announced that the U.S. Food and Drug Administration (FDA) has...

Cambridge, MA, July 27, 2026 Insilico Medicine has announced that first-in-human Phase 1 clinical trial data for ISM6331, its...

SYDNEY, Australia – July 24, 2026 Immutep Limited has announced that an abstract from its investigator-initiated Phase II EFTISARC-NEO...

ROCKVILLE, MD, July 23, 2026 MacroGenics, Inc. announced a significant clinical update from its ongoing Phase 1 study of...

RAMAT GAN, Israel, July 20, 2026 Can-Fite BioPharma Ltd. (NYSE American: CANF) announced that positive Phase 2a clinical trial...